Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density

Clinical trial NCT00896532 · COMPLETED

Trial details

NCT number: NCT00896532
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Low Bone Mineral Density Postmenopausal Osteoporosis

Start date: 2009-06-03
Primary completion: 2011-02-21
Enrollment: 419

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.